Notably, the PFS of TFE3/TFEB-rearranged RCC was significantly longer than papillary RCC and unclassified RCC (p = 0.001), with a median PFS of 15.3, 8.1 and 6.0 months, respectively (Figure 2a). Here, TFE3 is linked to renal cell carcinoma.